Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 65 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 9328142

    Lipopeptide inhibitors of RAS oncoproteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  2. US 9328129

    Peptidomimetic inhibitors of PSMA

    The Regents of the University of California · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  3. US 9321763

    Protein kinase C inhibitors and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  4. US 9320786

    Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  5. US 9320734

    Small molecule inhibitors of the pleckstrin homology domain and methods for using same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  6. US 9309250

    Substituted pyrrolo[2,3-b]pyrazines as ATR kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  7. US 9309231

    Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  8. US 9309237

    HIV inhibitors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  9. US 9309279

    Macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  10. US 9309232

    Synthesis of novel inhibitors of isoprenoid biosynthesis

    Beryllium Discovery Corp. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  11. US 9303042

    Triazolothienopyrimidine compound inhibitors of urea transporters and methods of using inhibitors

    The Regents of the University of California · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  12. US 9303061

    Spiro compounds as Hepatitis C virus inhibitors

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  13. US 9301947

    Ryanodine receptor inhibitors for treatment of T-cell mediated disorders

    The Regents of the University of California · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  14. US 9296701

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted

  15. US 9296730

    Aurora kinase inhibitors

    Regents of the University of Minnesota · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted

  16. US 9295754

    Noggin inhibitory compositions for ossification and methods related thereto

    United States Government as represented by the Department of Veterans Affairs · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted

  17. US 9296693

    Acyl piperidine inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted Mar 29, 2016 · Expires Mar 24, 2036

    granted

  18. US 9290752

    Process for enhancing the amylase inhibitory efficacy from phaseolus vulgaris extracts

    Sunny Delight Beverages Co. · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  19. US 9290456

    Pyridazinone compounds and their use as DAAO inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  20. US 9290574

    Methods for treating eosinophilic esophagitis by administering an IL-4R inhibitor

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  21. US 9278089

    Method of treating HCV infection with a small molecule CHK2 inhibitor

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 8, 2016 · Expires Mar 3, 2036

    granted

  22. US 9272023

    Use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  23. US 9271962

    Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors

    Northwestern University · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

  24. US 9266813

    Stilbenoid compound as inhibitor for squamous carcinoma and hepatoma and uses thereof

    China Medical University · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.